In Silico and In Vitro Analysis of MAP3773c Protein from Mycobacterium avium subsp. Paratuberculosis

Esteban Hernández-Guevara1, José A Gutiérrez-Pabello2, Kaina Quintero-Chávez3

  • 1Facultad de Odontología, Universidad Autónoma de Baja California, Tijuana 22390, Mexico.

Biology
|August 26, 2022
PubMed

Insights

Researchers investigated the MAP3773c protein in Mycobacterium avium subsp. paratuberculosis (MAP), a pathogen causing paratuberculosis. This protein has two metal-binding sites and contains structural zinc, suggesting potential as a therapeutic target.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Paratuberculosis is caused by Mycobacterium avium subsp. paratuberculosis (MAP).
  • Understanding MAP pathogenicity proteins is crucial for developing therapeutics and vaccines.
  • MAP3773c was identified as a protein of interest for investigation.

Purpose of the Study:

  • To investigate the MAP3773c protein from MAP.
  • To characterize its structure and function, particularly its metal-binding capabilities.
  • To assess its potential as a therapeutic or vaccine target.

Main Methods:

  • In silico molecular modeling and docking studies.
  • Cloning, expression, and purification of recombinant MAP3773c.
  • Biochemical characterization including SDS-PAGE, PAR staining, LC-MS, and BN-SDS-PAGE/BN-Western blotting.

Main Results:

  • MAP3773c shares 34% similarity with Mycobacterium tuberculosis FurB, a zinc uptake regulator.
  • Docking analysis revealed two metal-binding sites in MAP3773c.
  • Purified MAP3773c exists as a monomer and contains structural Zn2+.
  • Structural zinc coordination was confirmed in the purified protein.

Conclusions:

  • MAP3773c exhibits characteristics of a Fur-type protein.
  • The protein possesses two metal-binding sites, one coordinating structural zinc.
  • These findings highlight MAP3773c as a potential target for paratuberculosis intervention strategies.

Related Concept Videos